Definium Therapeutics Prices $700M Public Offering
Definium Therapeutics announced the pricing of an upsized public offering, raising approximately $700 million in gross proceeds.

Definium Therapeutics announced the pricing of an upsized public offering, raising approximately $700 million in gross proceeds.

The U.S. Supreme Court has ruled that Exxon Mobil can sue Cuban state-owned companies in U.S. courts for property confiscated decades ago.

A recent study reveals ARMN as a leading pick among analysts covering the Metals Channel Global Mining Titans Index, highlighting its strong...

Orion Digital Corp. (NASDAQ: ORIO, TSX: ORIO) announced today that all resolutions, including director elections and auditor appointments, were approved at its...

FedEx projects CY 2026 adjusted EPS of $16.90-$18.10, allocating $3.9B for CapEx and up to $1B for share buybacks.

Live cattle futures experienced declines across most contracts on Tuesday, June 23, 2026, even as wholesale boxed beef prices surged, driven by...

Faircourt Asset Management Inc. announced a $0.034 per share monthly distribution for Faircourt Gold Income Corp. (CBOE:FGX), payable July 15, 2026. The...

California's attorney general's office plans to sue the Trump administration over the Interior Department's buyout deal that canceled an offshore wind project...

Shares of Coeur Mining Inc (CDE) are now available at a 4.9% discount compared to EVP Aoife McGrath's recent $10,763 insider investment,...